MIM
ASMB icon

Monashee Investment Management’s Assembly Biosciences ASMB Stock Holding History

Monashee Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,083
Closed -$1.74M – 64
2019
Q4 		$1.74M Buy
+7,083
New +$1.3M 1.62% 22
2015
Q2 		– Sell
-4,000
Closed -$636K – 71
2015
Q1 		$636K Buy
+4,000
New +$541K 0.4% 54

Other funds holding ASMB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Monashee Investment Management's ASMB Position: Q1 2020 in Review

Monashee Investment Management sold out of Assembly Biosciences (ASMB) in Q1 2020, closing a stake of 7,083 shares — an estimated $1.74M sold.

Monashee Investment Management first reported a position in ASMB in Q1 2015 and held it in 2 quarters. The position peaked at $1.74M in Q4 2019. 98 funds tracked by Wall St. Rank hold ASMB as of Q1 2020.

  • Monashee Investment Management reported no remaining Assembly Biosciences position as of Q1 2020 after selling out during the quarter.
  • Monashee Investment Management sold 7,083 Assembly Biosciences shares in Q1 2020, an estimated $1.74M.
  • Monashee Investment Management first reported a position in Assembly Biosciences in Q1 2015 and held it in 2 quarters.
  • Monashee Investment Management's Assembly Biosciences position peaked at $1.74M in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2020.

Based on Monashee Investment Management's 13F filing for Q1 2020, filed 13 May 2020.